Phase Holographic Imaging PHI AB

Equities

PHI

SE0005504636

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 04:30:00 31/01/2024 am IST 5-day change 1st Jan Change
6.46 SEK -4.44% Intraday chart for Phase Holographic Imaging PHI AB -.--% +8.39%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Phase Holographic Imaging Obtains SEK7 Million Loan Agreement MT
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member CI
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine CI
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024 CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
European Patent Office Intends to Grant Phase Holographic Imaging AB Patent on Synthetic Antibodies CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023 CI
Phase Holographic Imaging Phi AB Elects Goran Dubravcic Elected as A New Member of the Board CI
Altium Mitkap AG acquired a 11.8% stake in Phase Holographic Imaging PHI AB from Formue Nord A/S. CI
PHI expands its global network to India CI
Phase Holographic Imaging Announces Management Changes CI
Phase Holographic Imaging PHI AB Announces Management Changes CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022 CI
Phase Holographic Imaging Announces Opening A New Development Office in the U.S CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2022 CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2022 CI
PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine CI
Phase Holographic Imaging Installs Holomonitor Fluorescence Now At Novo Nordisk A/S CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022 CI
Phase Holographic Imaging Phi AB Announces Sales Results for the Three Months and Full Year Ended January 2022 CI
Phase Holographic Imaging PHI AB Moves to New Premises CI
Phase Holographic Imaging Introduces Non-Invasive Fluorescence Units CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021 CI
Chart Phase Holographic Imaging PHI AB
More charts
Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Company’s product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.
More about the company
  1. Stock Market
  2. Equities
  3. PHI Stock
  4. News Phase Holographic Imaging PHI AB
  5. Phase Holographic Imaging Obtains SEK7 Million Loan Agreement